Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats

Baltogiannis, Giannis; Tsalikakis, Dimitrios G.; Mitsi, A.C.; Hatzistergos, Konstantinos E.; Elaiopoulos, Dimitrios; Fotiadis, Dimitrios I.; Kyriakides, Zenon S.; Kolettis, Theofilos M.

doi:10.1016/j.cardiores.2005.04.020

Cited by 47 publications

(45 citation statements)

References 37 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…(Baltogiannis et al, 2005;Crockett et al, 2001;Merkely et al, 2000;Xu et al, 2003). However, to date, anti-arrhythmic effects of selective ETR antagonists on myocardial ischemia and reperfusion remain controversial (Vago et al, 2002).…”

Section: Introductionmentioning

confidence: 92%

Up-regulated inflammatory factors endothelin, NFκB, TNFα and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats

2006

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 92%

Up-regulated inflammatory factors endothelin, NFκB, TNFα and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats

2006

View full text Add to dashboard Cite

“…Myocardial infarction was generated in vivo as previously described (1,9). In brief, animals were intubated and mechanically ventilated as outlined above.…”

Section: Methodsmentioning

confidence: 99%

Chronic skeletal muscle ischemia preserves coronary flow in the ischemic rat heart

Varnavas

Kontaras

Glava

et al. 2011

American Journal of Physiology-Heart and Circulatory Physiology

View full text Add to dashboard Cite

Varnavas VC, Kontaras K, Glava C, Maniotis CD, Koutouzis M, Baltogiannis GG, Papalois A, Kolettis TM, Kyriakides ZS. Chronic skeletal muscle ischemia preserves coronary flow in the ischemic rat heart. Am J Physiol Heart Circ Physiol 301: H1229-H1235, 2011. First published July 15, 2011; doi:10.1152/ajpheart.00232.2011.-Chronic skeletal muscle ischemia confers cytoprotection to the ventricular myocardium during infarction, but the underlying mechanisms remain unclear. Although neovascularization in the left ventricular myocardium has been proposed as a possible mechanism, the functional capacity of such vessels has not been studied. We examined the effects of chronic limb ischemia on infarct size, coronary blood flow, and left ventricular function after ischemia-reperfusion. Hindlimb ischemia was induced in 65 Wistar rats by excision of the left femoral artery, whereas 65 rats were sham operated. After 4 wk, myocardial infarction was generated by permanent coronary artery ligation. Infarct size was measured 24 h postligation. Left ventricular function was evaluated in isolated hearts after ischemia-reperfusion, 4 wk after limb ischemia. Neovascularization was assessed by immunohistochemistry, and coronary flow was measured under maximum vasodilatation at different perfusion pressures before and after coronary ligation. Infarct size was smaller after limb ischemia compared with controls (24.4 Ϯ 8.1% vs. 46.2 Ϯ 9.5% of the ventricle and 47.6 Ϯ 8.7% vs. 80.1 Ϯ 9.3% of the ischemic area, respectively). Indexes of left ventricular function at the end of reperfusion (divided by baseline values) were improved after limb ischemia (developed pressure: 0.68 Ϯ 0.06 vs. 0.59 Ϯ 0.05, P ϭ 0.008; maximum ϩdP/dt: 0.70 Ϯ 0.08 vs. 0.59 Ϯ 0.04, P ϭ 0.004; and maximum ϪdP/dt: 0.86 Ϯ 0.14 vs. 0.72 Ϯ 0.10, P ϭ 0.041). Coronary vessel density was markedly higher (P ϭ 0.00021) in limb ischemic rats. In contrast to controls (F ϭ 5.65, P ϭ 0.00182), where coronary flow decreased, it remained unchanged (F ϭ 1.36, P ϭ 0.28) after ligation in limb ischemic rats. In conclusion, chronic hindlimb ischemia decreases infarct size and attenuates left ventricular dysfunction by increasing coronary collateral vessel density and blood flow. chronic limb ischemia; infarct size; left ventricular function ISCHEMIC MYOCARDIAL PRECONDITIONING describes the situation where the ventricular myocardium is rendered more resistant to a prolonged ischemic insult by preceding brief periods of ischemia (22,23). In the experimental setting, a further approach of myocardial protection has been observed after short ischemic episodes of peripheral tissues, a process termed remote ischemic preconditioning (2,14). Cytoprotection in the heart has been demonstrated after ischemia in a variety of peripheral tissues, such as the mesenterium, kidney, and skeletal muscle (12, 32). Of these, skeletal muscles have attracted considerable scientific interest because they are easily accessible and can be manipulated without major risk in the clinical setting, should this method pr...

show abstract

“…6 In addition, acute and chronic ET1 receptor type-A (ETRA) blockade was found to improve cardiac function and reduce the incidence of arrhythmia in rats with myocardial infarction. 7,8 Thus, antagonism of ET1 signaling is potentially a desirable therapeutic strategy. As such, we hypothesized that blockade of the ET1R may have a cardioprotective effect in myocarditis, and we investigated the therapeutic use of ET1 antagonist, bosentan, in a mouse model of viral myocarditis.…”

mentioning

confidence: 99%

Bosentan Enhances Viral Load via Endothelin-1 Receptor Type-A–Mediated p38 Mitogen-Activated Protein Kinase Activation While Improving Cardiac Function During Coxsackievirus-Induced Myocarditis

Marchant

Dou

Luo

et al. 2009

Circulation Research

View full text Add to dashboard Cite

show abstract

Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats

Abstract: Acute ETA blockade reduces the incidence of VT/V F during the first 24-h post-MI in the rat, through a decrease in the dispersion of repolarization.

Cited by 47 publications

References 37 publications

Up-regulated inflammatory factors endothelin, NFκB, TNFα and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats

Up-regulated inflammatory factors endothelin, NFκB, TNFα and iNOS involved in exaggerated cardiac arrhythmias in l-thyroxine-induced cardiomyopathy are suppressed by darusentan in rats

Chronic skeletal muscle ischemia preserves coronary flow in the ischemic rat heart

Bosentan Enhances Viral Load via Endothelin-1 Receptor Type-A–Mediated p38 Mitogen-Activated Protein Kinase Activation While Improving Cardiac Function During Coxsackievirus-Induced Myocarditis

Contact Info

Product

Resources

About